InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Bush Tia L, Directeur Qualité. Officer active across 1 companies, notably Centessa Pharmaceuticals plc. In total, 4 disclosures have been recorded. Total volume traded: €119k. The latest transaction was filed on 16 November 2021 — Acquisition. Regulator: SEC (Form 4). All data is openly available.
Declarations4 total
€10,592995 shares@ €10.64530.0002% mcap17.7% of flow
Ordinary Shares
SEC:0000899243-21-045312·
Ideal exit: 13 Aug 2022 (T+270)
€10,592995 shares@ €10.64530.0002% mcap8.9% of flow
Ordinary Shares
SEC:0000899243-21-045312:0·
Ideal exit: 13 Aug 2022 (T+270)
€49,1413,000 shares@ €16.38020.0008% mcap82.3% of flow
Ordinary Shares
SEC:0000899243-21-022069·
Ideal exit: 27 Feb 2022 (T+270)
€49,1413,000 shares@ €16.38020.0008% mcap41.1% of flow
Ordinary Shares
SEC:0000899243-21-022069:0·
Ideal exit: 27 Feb 2022 (T+270)
4 of 4 declarations
About Bush Tia L
Tia L. Bush is the Chief Quality Officer at Centessa Pharmaceuticals plc. She is responsible for managing product quality and compliance. Bush plays a crucial role in quality assurance and continuous improvement.
